Edesa Biotech, Inc. - Common Shares — Financial Statements (NASDAQ:EDSA) | MetaTrader

Open full chart Full chart

News

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.95%

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.83%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.76%

Edesa Biotech stock surges on positive Phase 3 trial data

Edesa Biotech reports mortality reduction in phase 3 trial

Edesa Biotech increases at-the-market offering limit to $2.26 million

Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow (NASDAQ:EDSA) 2025-11-17

Edesa Biotech reports positive Phase 3 results for ARDS drug candidate

Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - AppLovin (NASDAQ:APP), Dutch Bros (NYSE:BROS)

Nasdaq Surges 150 Points; Cisco Earnings Top Views - AppLovin (NASDAQ:APP), Dutch Bros (NYSE:BROS)